Sage Journals: Discover world-class research

Free access

Research article

First published 2022-9

Regulatory Experience Assessing the Carcinogenic Potential of a Monoclonal Antibody Inhibiting PCSK9,Bococizumab,Including a 2-Year Carcinogenicity Study in Rats

Bernard S. Buetow, Gregg D Cappon, Laura M. Aschenbrenner [...]

International Journal of Toxicology

Retricted access

Review article

First published 2015-12

Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab

C. Michael White

Annals of Pharmacotherapy

Retricted access

Article commentary

First published 2017-7

New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials

Katrina L Ellis, Jing Pang, Carl J Schultz [...]

European Journal of Preventive Cardiology

Retricted access

Review article

First published 2014-2

Biologics for the Treatment of Dyslipidemias

Connie H. Yoon, Kristin Watson

Annals of Pharmacotherapy

Retricted access

Editorial

First published 2019-6

PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies

Massimiliano Ruscica, Gerald F Watts, Cesare R Sirtori

European Journal of Preventive Cardiology

Free access

Editorial

First published 2017-1

Hypothesis

Wenguang Wang, Chao Liu, Hongliang Cong

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Research article

First published 2018-7

The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia

C. Michael White

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Article commentary

First published 2023-09-07

Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36

Frank S. Fan

Tumor Biology

Open access

Review article

First published 2025

PCSK9 in critical illness – It’s not all about lipids

Emma Crossley, Jonathan A Silversides, Cecilia M O’Kane [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Free access

Research article

First published 2015-3

Proprotein Convertase Subtilisin/Kexin 9 Inhibitors

Simona Dragan, Maria-Corina Serban, Maciej Banach

Journal of Cardiovascular Pharmacology and Therapeutics

Search results